PARK HA BIOLOGICAL TECHNOLOG (BYAH) Stock Price, Forecast & Analysis

NASDAQ:BYAH • KYG6925R1020

0.069 USD
0 (-3.9%)
At close: Feb 12, 2026
0.0723 USD
+0 (+4.78%)
Pre-Market: 2/13/2026, 7:00:00 AM

BYAH Key Statistics, Chart & Performance

Key Statistics
Market Cap2.34M
Revenue(TTM)3.62M
Net Income(TTM)-19.36M
Shares33.87M
Float12.32M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.1
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2024-12-27
Sector
GICS IndustrySpecialty Retail
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS SubIndustryOther Specialty Retail
BYAH short term performance overview.The bars show the price performance of BYAH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

BYAH long term performance overview.The bars show the price performance of BYAH in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of BYAH is 0.069 USD. In the past month the price decreased by -55.54%.

PARK HA BIOLOGICAL TECHNOLOG / BYAH Daily stock chart

BYAH Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
BYAH Full Technical Analysis Report

BYAH Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to BYAH. No worries on liquidiy or solvency for BYAH as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
BYAH Full Fundamental Analysis Report

BYAH Financial Highlights

Over the last trailing twelve months BYAH reported a non-GAAP Earnings per Share(EPS) of -0.1. The EPS decreased by -2189.24% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -331.89%
ROE -455.43%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-38931.58%
Sales Q2Q%45.29%
EPS 1Y (TTM)-2189.24%
Revenue 1Y (TTM)9.33%
BYAH financials

BYAH Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
BYAH Analyst EstimatesBYAH Analyst Ratings

BYAH Ownership

Ownership
Inst Owners0.35%
Ins OwnersN/A
Short Float %2.29%
Short Ratio0.12
BYAH Ownership

BYAH Competitors/Peers

The largest stocks on the US markets in the "Other Specialty Retail" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ULTA ULTA BEAUTY INC23.1829.916B
TSCO TRACTOR SUPPLY COMPANY24.2828.75B
DKS DICK'S SPORTING GOODS INC13.3617.875B
FIVE FIVE BELOW28.7511.098B
CHWY CHEWY INC - CLASS A27.5810.076B
BBWI BATH & BODY WORKS INC8.734.68B
ASO ACADEMY SPORTS & OUTDOORS IN8.853.847B
POWWP OUTDOOR HOLDING CO - POWW 8 3/4 PERP N/A2.844B
WRBY WARBY PARKER INC-CLASS A42.712.611B
EYE NATIONAL VISION HOLDINGS INC30.082.22B

About BYAH

Company Profile

BYAH logo image Park Ha Biological Technology Co. Ltd. is a holding company, which engages in the manufacture of skincare and cosmetic products. The company is headquartered in Wuxi, Jiangsu and currently employs 31 full-time employees. The company went IPO on 2024-12-27. The firm mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The firm's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The firm mainly conducts its business in domestic market.

Company Info

PARK HA BIOLOGICAL TECHNOLOG

14F, Building 3, No. 50 Xiuxi Road

Wuxi JIANGSU CN

Employees: 31

BYAH Company Website

Phone: 864000127562

PARK HA BIOLOGICAL TECHNOLOG / BYAH FAQ

Can you describe the business of PARK HA BIOLOGICAL TECHNOLOG?

Park Ha Biological Technology Co. Ltd. is a holding company, which engages in the manufacture of skincare and cosmetic products. The company is headquartered in Wuxi, Jiangsu and currently employs 31 full-time employees. The company went IPO on 2024-12-27. The firm mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The firm's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The firm mainly conducts its business in domestic market.


Can you provide the latest stock price for PARK HA BIOLOGICAL TECHNOLOG?

The current stock price of BYAH is 0.069 USD. The price decreased by -3.9% in the last trading session.


What is the dividend status of PARK HA BIOLOGICAL TECHNOLOG?

BYAH does not pay a dividend.


What is the ChartMill rating of PARK HA BIOLOGICAL TECHNOLOG stock?

BYAH has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Who owns PARK HA BIOLOGICAL TECHNOLOG?

You can find the ownership structure of PARK HA BIOLOGICAL TECHNOLOG (BYAH) on the Ownership tab.


What is the Short Interest ratio of PARK HA BIOLOGICAL TECHNOLOG (BYAH) stock?

The outstanding short interest for PARK HA BIOLOGICAL TECHNOLOG (BYAH) is 2.29% of its float.